Saltar al contenido
Merck

Hijacking Methyl Reader Proteins for Nuclear-Specific Protein Degradation.

Journal of the American Chemical Society (2022-03-22)
Dhanusha A Nalawansha, Ke Li, John Hines, Craig M Crews
RESUMEN

Targeted protein degradation (TPD) by PROTACs is a promising strategy to control disease-causing protein levels within the cell. While TPD is emerging as an innovative drug discovery paradigm, there are currently only a limited number of E3 ligase:ligand pairs that are employed to induce protein degradation. Herein, we report a novel approach to induce protein degradation by hijacking a methyl reader:E3 ligase complex. L3MBTL3 is a methyl-lysine reader protein that binds to the Cul4DCAF5 E3 ligase complex and targets methylated proteins for proteasomal degradation. By co-opting this natural mechanism, we report the design and biological evaluation of L3MBTL3-recruiting PROTACs and demonstrate nuclear-specific degradation of FKBP12 and BRD2. We envision this as a generalizable approach to utilize other reader protein-associated E3 ligase complexes in PROTAC design to expand the E3 ligase toolbox and explore the full potential of TPD.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Millipore
Microesferas magnéticas anti-FLAG® M2, affinity isolated antibody
Sigma-Aldrich
Anticuerpo anti-α-tubulina, clon DM1A, conjugado con Alexa Fluor488, clone DM1A, Upstate®, from mouse